Why is Vaishali Pharma falling/rising?

As of 26-Aug, Vaishali Pharma Ltd's stock price is currently at 11.89, reflecting a decrease of 0.19, or 1.57%. The stock has underperformed significantly, with a 1-week return of -5.48% and a 1-month return of -4.04%. Today's performance indicates that it has outperformed its sector by 0.31%, but it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 42.23% compared to the 5-day average. The company has also shown weak long-term fundamental strength, evidenced by a -145.73% CAGR growth in operating profits over the last five years and a poor EBIT to interest ratio of 1.68, which negatively impacts its ability to service debt.
In the broader market context, Vaishali Pharma's recent performance contrasts sharply with the benchmark, as it has generated a return of -30.61% over the past year, while the Sensex has only declined by 1.19%. This underperformance is further highlighted by the company's flat results in June, where profit after tax fell by 24.7%. The stock's risk profile is concerning, with negative EBITDA and a return on equity of only 8.96%, indicating low profitability per unit of shareholders' funds. Overall, the combination of weak financial fundamentals, declining investor interest, and poor relative performance against the benchmark suggests a challenging environment for Vaishali Pharma, contributing to its current downward price movement.